Who makes 0.25 % Miconazole Nitrate Ointment?

0.25 % Miconazole Nitrate Ointment is developed by Stiefel, a GSK Company.

What development phase is 0.25 % Miconazole Nitrate Ointment in?

0.25 % Miconazole Nitrate Ointment is FDA-approved (marketed).

Last reviewed 2026-05-15 · How we verify

0.25 % Miconazole Nitrate Ointment

Stiefel, a GSK Company · FDA-approved active Small molecule Quality 1/100

At a glance

Generic name	0.25 % Miconazole Nitrate Ointment
Also known as	Vusion
Sponsor	Stiefel, a GSK Company
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

0.25 % Miconazole Nitrate Ointment CI brief — competitive landscape report
0.25 % Miconazole Nitrate Ointment updates RSS · CI watch RSS
Stiefel, a GSK Company portfolio CI